跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
C9-4
首页
药物
C9-4
C9-4
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
US 6972343 B1
申请人: CENTRE NAT RECH SCIENT
优先权: 1999
CN
EP
US
WO
7 件公开
PROCESS FOR THE PREPARATION OF ATORVASTATIN AND INTERMEDIATES
US 2006194867 A1
申请人: APOTEX PHARMACHEM INC
优先权: 2005
US
6 件公开
Lipid dipeptide and gel
US 9265833 B2
申请人: MIYAMOTO MISAO
优先权: 2008
US
5 件公开
OPHTHALMIC FORMULATION
US 2014377335 A1
申请人: UNIV WESTERN SYDNEY
优先权: 2011
US
5 件公开
CHEMICAL COMPOSITION WITH HYDROGEN PEROXIDE AND A NANOEMULSION OF LONG-CHAINED ALCOHOLS
EP 2680818 B1
申请人: DEB IP LTD
优先权: 2011
EP
US
WO
4 件公开
Process for the production of substituted 2-[2-(phenyl)ethylamino] alkaneamide derivatives
US 12291495 B2
申请人: NEWRON PHARM SPA
优先权: 2019
CN
US
WO
4 件公开
MIXTURE OF ALKYL POLYGLYCOSIDES
WO 2024249229 A1
申请人: DOW GLOBAL TECHNOLOGIES LLC
优先权: 2023
CN
WO
4 件公开
NOVEL QUINUCLIDINE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
US 2010234333 A1
申请人: FERNANDEZ FORNER MARIA DOLORS
优先权: 2000
US
4 件公开
MULTIGENE CONSTRUCTS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER COMPLEMENT DYSREGULATION-RELATED CONDITIONS
EP 4387678 A4
申请人: UNIV UTAH RES FOUND
优先权: 2021
EP
US
WO
3 件公开
ANTI-RADICAL AGENTS
EP 1827406 B1
申请人: BASF SE
优先权: 2005
EP
US
3 件公开
第 1 / 7 页
上一页
下一页
药物
反馈